New York · 2025 Regular Session · Bill
S 5314: Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 5314 is a bill introduced in the New York Senate on February 20, 2025. According to its official title, it concerns: Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy. Primary sponsor: Jamaal Bailey (Democratic/Working Families). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.
Sponsors
Sponsors by party (alphabetical): Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jamaal Bailey | Primary sponsor | Democratic/Working Families | Senate | 36 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE
- REFERRED TO INSURANCE